Liquidia Corporation LQDA Return on equity

Return on equity at other companies

Tenet HealthcareTHC

75.5%+9.1pp

United TherapeuticsUTHR

19.3%0.0pp

Mirum Pharmaceuticals, Inc.MIRM

-335.8%-377pp

Theravance BiopharmaTBPH

50.2%+36.2pp

Zevra Therapeutics, Inc.ZVRA

34.8%+31.3pp

Aurinia PharmaceuticalsAUPH

66.1%+48.8pp

FAQ

What is Liquidia Corporation's return on equity?

Liquidia Corporation (LQDA) reported return on equity of -181% in Q3 2025.

How has Liquidia Corporation's return on equity changed year-over-year?

Liquidia Corporation's return on equity decreased by 24.1% year-over-year, from -145.8% to -181%.

What is the long-term trend for Liquidia Corporation's return on equity?

Over 4 years (2020 to 2024), Liquidia Corporation's return on equity has grown at a 15.8% compound annual growth rate (CAGR), from -112.7% to -202.6%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.